We hereby submit intimation regarding Schedule of Analyst/Investor Meet.

YH/SE/53/2026-27 September 23, 2026 The Listing Department Dept. of Listing Operations National Stock Exchange of India Limited BSE Limited, Exchange Plaza, 5th Floor, Plot No. C/1 Phiroze Jeejeebhoy Towers, G Block, Bandra-Kurla Complex, Bandra (E) Dalal Street, Mumbai – 400 051, India Mumbai - 400001, India Symbol: YATHARTH Scrip Code: 543950 ISIN: INE0JO301016 ISIN: INE0JO301016 Subject: Intimation of Schedule of Analysts/Investors meet /conference under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, Pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, we hereby inform you that the management of the Company will be participating in the following Analyst / Investor’s Meeting / Conference. The details are as below: Particulars of Investor Type of Event/ S.No. Day & Date Location Event/Meeting meeting Monday, Nuvama Emerging India Investor 1. September 28, Mumbai CEO Forum Conference 2026 Tuesday, One to One and 2. September 29, Sell-Side meets Mumbai Group 2026 The date of the aforesaid meeting/conference is subject to change due to exigencies on the part of Investors/Company. No Unpublished Price Sensitive Information will be shared at the above-mentioned meeting. The above information will also be made available on website of the Company at https://www.yatharthhospitals.com/investors/corporate-announcements. This is for your kind information and records. Thanking You Yours Faithfully, For Yatharth Hospital & Trauma Care Services Limited Ritesh Mishra Company Secretary & Compliance Officer M. No. A51166